0.4150CAD-9.78%Mkt Cap: 27.90M $P/E: —1d ago
Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.17BUSDP/E 26.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap27.90M $
Enterprise Value22.12M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-13.41M $
Revenue/Share—
Last Price0.4150 CAD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees15
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.80
PEG—
EV/EBITDA-1.36
EV/Revenue—
P/S—
P/B13.83
EPS (TTM)-0.22
EPS (Forward)-0.23
52W Range
0.33505% of range1.970
52W High1.970 CAD
52W Low0.3350 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-741.70%
ROA-217.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.05M $
CapEx (TTM)—
FCF Margin—
FCF Yield-28.01%
Net Debt-4.07M $
Net Debt/EBITDA0.25
Balance Sheet
Debt/Equity0.05
Current Ratio1.25
Quick Ratio1.11
Book Value/Sh0.0300 CAD
Cash/Share0.0660 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 3, 2017
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)3.200 CAD
Upside (mean)+671.1%
Target Range1.600 CAD – 4.000 CAD
CAD1.600+671.1% to meanCAD4.000
# Analysts3
Ownership
Shares Out.92.30M
Float69.83M
Insiders19.40%
Institutions0.00%
Short Interest
Short Ratio3.4d
Short % Float0.47%
Short % Out.0.20%
Shares Short181.74K
Short (prev mo.)295.76K
Technical
SMA 500.3894 (+6.6%)
SMA 2000.7603 (-45.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)50.04K
Avg Vol (10d)51.24K
Technical Indicators
RSI (14)57.2
MACD0.0093
MACD Signal-0.0006
MACD Hist.+0.0099
BB Upper0.4358 CAD
BB Middle0.3743 CAD
BB Lower0.3127 CAD
BB Width32.91%
ATR (14)0.0252 CAD
Vol Ratio (20d)0.61x